NYLIM
KRYS icon

New York Life Investment Management’s Krystal Biotech KRYS Stock Holding History

New York Life Investment Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
+3,167
New +$946K 0.01% 660
2024
Q1 		– Sell
-4,314
Closed -$535K – 1438
2023
Q4 		$535K Sell
4,314
-126
-3% -$14K 0.01% 803
2023
Q3 		$515K Sell
4,440
-708
-14% -$86.4K 0.01% 764
2023
Q2 		$604K Sell
5,148
-757
-13% -$77.3K 0.01% 650
2023
Q1 		$473K Buy
+5,905
New +$464K 0.01% 1041

Other funds holding KRYS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

New York Life Investment Management's KRYS Position: Q2 2026 in Review

New York Life Investment Management opened a new position in Krystal Biotech (KRYS) in Q2 2026: 3,167 shares worth $1.18M. The stake represents 0.01% of the portfolio and ranks #660 among its holdings. This is a return to the name: New York Life Investment Management previously reported a position in KRYS as recently as Q4 2023.

New York Life Investment Management first reported a position in KRYS in Q1 2023 and has held it in 5 quarters since. 207 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • New York Life Investment Management held 3,167 shares of Krystal Biotech worth $1.18M as of Q2 2026.
  • Krystal Biotech was a new New York Life Investment Management position in Q2 2026.
  • Krystal Biotech made up 0.01% of New York Life Investment Management's portfolio in Q2 2026, its #660 holding.
  • New York Life Investment Management first reported a position in Krystal Biotech in Q1 2023 and has held it in 5 quarters since.
  • 207 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.